These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18636165)

  • 1. Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells.
    Sobotkova E; Duskova M; Eckschlager T; Vonka V
    Int J Oncol; 2008 Aug; 33(2):421-6. PubMed ID: 18636165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.
    Nemeckova S; Smahel M; Hainz P; Mackova J; Zurkova K; Gabriel P; Indrova M; Kutinova L
    Neoplasma; 2007; 54(4):326-33. PubMed ID: 17822323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.
    Sobotkova E; Duskova M; Tachezy R; Petrackova M; Vonka V
    Oncol Rep; 2009 Mar; 21(3):793-9. PubMed ID: 19212641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental therapy of HPV16 induced tumors with IL12 expressed by recombinant vaccinia virus in mice.
    Nemeckova S; Sroller V; Hainz P; Krystofova J; Smahel M; Kutinova L
    Int J Mol Med; 2003 Nov; 12(5):789-96. PubMed ID: 14533011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells.
    Lakatosová-Andelová M; Jinoch P; Dusková M; Marinov I; Vonka V
    Int J Oncol; 2008 Jan; 32(1):265-71. PubMed ID: 18097567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immunization with DNA and transduced tumor cells expressing mouse GM-CSF or IL-2.
    Rittich S; Duskova M; Mackova J; Pokorna D; Jinoch P; Smahel M
    Oncol Rep; 2005 Feb; 13(2):311-7. PubMed ID: 15643517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
    Sobotková E; Dusková M; Smahel M; Holán V; Janousková O; Vonka V
    Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
    Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.
    Moret-Tatay I; Díaz J; Marco FM; Crespo A; Aliño SF
    Cancer Gene Ther; 2003 Dec; 10(12):887-97. PubMed ID: 14712315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
    Kohno SI; Luo C; Nawa A; Fujimoto Y; Watanabe D; Goshima F; Tsurumi T; Nishiyama Y
    Cancer Gene Ther; 2007 Nov; 14(11):918-26. PubMed ID: 17693992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
    Sung CK; Choi B; Wanna G; Genden EM; Woo SL; Shin EJ
    Laryngoscope; 2008 Feb; 118(2):237-42. PubMed ID: 18043494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining radiation therapy with interleukin-3 gene immunotherapy.
    Chiang CS; Hong JH; Wu YC; McBride WH; Dougherty GJ
    Cancer Gene Ther; 2000 Aug; 7(8):1172-8. PubMed ID: 10975678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
    Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic reovirus therapy of metastatic cancer in immune-competent mice.
    Hirasawa K; Nishikawa SG; Norman KL; Coffey MC; Thompson BG; Yoon CS; Waisman DM; Lee PW
    Cancer Res; 2003 Jan; 63(2):348-53. PubMed ID: 12543787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression promotes reovirus therapy of colorectal liver metastases.
    Smakman N; van der Bilt JD; van den Wollenberg DJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
    Cancer Gene Ther; 2006 Aug; 13(8):815-8. PubMed ID: 16543920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy.
    Janke M; Peeters B; de Leeuw O; Moorman R; Arnold A; Fournier P; Schirrmacher V
    Gene Ther; 2007 Dec; 14(23):1639-49. PubMed ID: 17914407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.
    Lin JM; Li B; Rimmer E; VanRoey M; Jooss K
    Exp Hematol; 2008 Mar; 36(3):319-28. PubMed ID: 18279719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-tumor effect of combination radio- and immunotherapy by electro-gene therapy plus intra-tumor injection of dendritic cells.
    Wang YS; Tsang YW; Chi CH; Chang CC; Chu RM; Chi KH
    Cancer Lett; 2008 Aug; 266(2):275-85. PubMed ID: 18397820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.